Evolutionary adaptations to risk of cancer: Evidence from cancer resistance in elephants

JAMA - Journal of the American Medical Association

Volumn 314, Issue 17, 2015, Pages 1806-1807

  Greaves, Mel ^a   Ermini, Luca ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; MELANOCORTIN 1 RECEPTOR; PROTEIN MDM2; PROTEIN P53;

AFRICA; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RESISTANCE; CANCER RISK; CAUSE OF DEATH; CELL ADHESION; CELL CYCLE; CELL DIFFERENTIATION; CELL DIVISION; CELL GROWTH; CELL PROLIFERATION; DIETARY INTAKE; DNA DAMAGE; DNA REPAIR; EDITORIAL; ELEPHANT; EVOLUTIONARY ADAPTATION; FIBROBLAST; GENE DOSAGE; GENE LOSS; GENE SEQUENCE; GENETIC VARIABILITY; GENOMICS; HABIT; HUMAN; HYRAX; INFLAMMATION; INTESTINE EPITHELIUM; INTRON; LIFESTYLE MODIFICATION; LONGEVITY; MOLECULAR CLONING; NONHUMAN; PRIORITY JOURNAL; PROCAVIA CAPENSIS; PROTEIN BINDING; PROTEIN FUNCTION; PSEUDOGENE; REPRODUCTIVE HEALTH; SKIN CANCER; SKIN PIGMENTATION; SMOKING; STEADY STATE; STEM CELL; SUNSOAKING; TUMOR SUPPRESSOR GENE; UNITED STATES; X IRRADIATION; ANIMAL; DISEASE RESISTANCE; EVOLUTION; GENETICS; NEOPLASM;

ANIMALS; BIOLOGICAL EVOLUTION; DISEASE RESISTANCE; DNA DAMAGE; ELEPHANTS; HUMANS; NEOPLASMS;

EID: 84946091610     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2015.13153     Document Type: Editorial

References (16)

1. Peto R. Quantitative implications of the appr oximate irrelevance of mammalian body size and lifespan to lifelong cancer risk. Philos Trans R Soc Lond B Biol Sci. 2015;370(1673):20150198.
2. Caulin AF, Maley CC. Peto's paradox: evolution's prescription for cancer prevention. Trends Ecol Evol. 2011;26(4):175-182.
3. Aktipis CA, Boddy AM, Jansen G, et al. Cancer across the tree of life: cooperation and cheating in multicellularity. Philos Trans R Soc Lond B Biol Sci. 2015;370(1673):20140219.
4. Schiffman J, Maley CC, Nunney L, HochbergM, Breen M, eds. Cancer across life: Peto's paradox and the promise of comparative oncology. Philos Trans R Soc Lond B Biol Sci 2015 370(1673, theme issue).
5. Greaves M. Evolutionary determinants of cancer. Cancer Discov. 2015;5(8):806-820.
6. Abegglen LM, Caulin AF, Chan A, et al. Potential mechanisms for cancer resistance in elephants and comparative cellular response to DNA damage in humans. JAMA. doi:10.1001/jama.2015.13134.
7. Tyner SD, Venkatachalam S, Choi J, et al. p53 mutant mice that display early ageing-Associated phenotypes. Nature. 2002;415(6867):45-53.
8. LuWJ, Amatruda JF, Abrams JM. p53 ancestry: gazing through an evolutionary lens. Nat Rev Cancer. 2009;9(10):758-762.
9. Zhao Y, Ren JL,Wang MY, et al. Codon 104 variation of p53 gene provides adaptive apoptotic responses to extre me environments in mammals of the Tibet plateau. Proc Natl Acad Sci U S A. 2013;110 (51):20639-20644.
10. Weiss KM. Are the known chronic diseases related to the human lifespan and its evolution? Am J Hum Biol. 1989;1:307-319.
11. Dang CV. Ametabolic perspective of Peto's paradox and cancer. Philos Trans R Soc Lond B Biol Sci. 2015;370(1673):20140223.
12. Keane M, Semeiks J,Webb AE, et al. Insights into the evolution of longevity from the bowhead whale genome. Cell Rep. 2015;10(1):112-122.
13. Gorbunova V, Seluanov A, Zhang Z, Gladyshev VN, Vijg J. Comparative genetics of longevity and cancer: insights from long-lived rodents. Nat Rev Genet. 2014;15(8):531-540.
14. Scheinfeldt LB, Tishkoff SA. Recent human adaptation: genomic approaches, interpretation and insights. Nat Rev Genet. 2013;14(10):692-702.
15. Greaves M.Was skin cancer a selective force for black pigmentation in early hominin evolution? Proc Biol Sci. 2014;281(1781):20132955.
16. Greaves M. Darwinian medicine: a case for cancer. Nat Rev Cancer. 2007;7(3):213-221.